An attorney in Los Angeles and San Francisco, California, Ben Lyon earned his law degree at Loyola Law School in Los Angeles. Since 2015, attorney Ben Lyon served as the general counsel and executive vice president of ImmixBiopharma, a biopharmaceutical company.
There is an ever-growing need for biopharmaceuticals around the world as the population looks toward less expensive options for medications. Biological drugs, produced from living sources, are far different from synthetic drugs. As with branded drugs with generic alternatives, biological drugs have biosimilars. Companies are working to produce biosimilars for up to 15 significant drugs that will reduce prices significantly.
Manufacturers have relied on Asia for their active pharmaceutical ingredients for a number of years, but now, manufacturers are looking for other sources. Sourcing ingredients from other areas will help ensure that there is enough to meet demand.
Research and development should also see a big push since governments and corporations see how crucial they are. Expect to see larger investments from both governments and private firms in the future of biopharmaceuticals.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.